|
2018
|
Invention
|
Formulation comprising a stabilized complex of corticotropin releasing hormone and alpha-2 macrog... |
|
2016
|
Invention
|
Treatment of medical conditions. A composition comprising CRH, CRH binding protein (CRH-BP), alph... |
|
2015
|
Invention
|
Treatment of diseases.
Provided are methods for the treatment of various neural disorders includ... |
|
|
Invention
|
Therapeutic agent.
Anti-HLA and other antibodies are present in goat serum after injection of HI... |
|
|
Invention
|
Formulation and method of manufacture. The present invention relates to a CRH formulation and to ... |
|
2014
|
Invention
|
Improved formulation. The present invention relates to a CRH formulation having improved stabilit... |
|
2013
|
Invention
|
Use of goat serum for veterinary treatment.
Methods for veterinary treatment of mammals are desc... |
|
|
Invention
|
Treatment of diseases.
Methods of treatment of various non-demyelinating and demyelinating neura... |
|
|
Invention
|
Treatment of hiv.
We describe methods of treatment of HIV using proopiomelanocortin (POMC) and c... |
|
|
G/S
|
Pharmaceutical preparations and substances for human and veterinary use, namely, anti-inflammator... |
|
|
Invention
|
Treatment of ms with goat serum.
A serum composition from a goat immunised with HIV contains ant... |
|
|
Invention
|
Formulation comprising crh and alpha-2 macroglobulin. The present invention relates to a CRH form... |
|
|
Invention
|
Formulation comprising crh and alpha - 2 - immunoglobulin. The present invention relates to a CRH... |
|
2012
|
Invention
|
Use of goat serum for veterinary treatment. Methods for veterinary treatment of mammals are descr... |
|
|
Invention
|
Medicament.
Analysis of a goat serum product with many therapeutic effects is described. The pro... |
|
2010
|
Invention
|
Use of a serum composition to reduce the levels of tnf and/or vegf in mammals. The invention rela... |
|
2007
|
Invention
|
Treatment of hiv. We describe methods of treatment of HIV using proopiomelanocortin (POMC) and co... |
|
2006
|
Invention
|
Combination therapy. The present invention describes a pharmaceutical composition comprising the ... |
|
|
Invention
|
Pharmaceutical composition comprising serum obtained from a naive mammal. Pharmaceutical composit... |
|
|
Invention
|
Bioactive compounds. Methods and compositions comprising bioactive molecules associated with anti... |
|
2005
|
G/S
|
Pharmaceutical preparations and substances for human and
veterinary use. |
|
|
Invention
|
Medicament. Analysis of a goat serum product with many therapeutic effects is described. The prod... |
|
|
Invention
|
Treatment of diseases. Methods of treatment of various non-demyelinating and demyelinating neural... |
|
|
Invention
|
Treatment of autoimmune disorders of the skin with a goat serum obtained from a goat challenged w... |
|
2004
|
Invention
|
Use of goat blood serum derived antibodies obtained after challenge with hiv lysate for veterinar... |
|
|
G/S
|
Pharmaceutical preparations and substances for human and veterinary use. Medical, veterinary and ... |
|
2003
|
Invention
|
Treatment of ms with goat serum. A serum composition from a goat immunised with HIV contains anti... |
|
2002
|
Invention
|
Use of polyclonal anti-hiv goat serum as a therapeutic agent. Anti-HLA and other antibodies are p... |
